Bartłomiej Łukaszuk Selected Research

thermozymocidin (myriocin)

3/2017	Myriocin treatment affects lipid metabolism in skeletal muscles of rats with streptozotocin-induced type 1 diabetes.
1/2015	Inhibition of Ceramide De Novo Synthesis Ameliorates Diet Induced Skeletal Muscles Insulin Resistance.
8/2014	Inhibition of ceramide de novo synthesis reduces liver lipid accumulation in rats with nonalcoholic fatty liver disease.
1/2014	Inhibition of ceramide de novo synthesis with myriocin affects lipid metabolism in the liver of rats with streptozotocin-induced type 1 diabetes.
1/2013	Effects of inhibition of serine palmitoyltransferase (SPT) and sphingosine kinase 1 (SphK1) on palmitate induced insulin resistance in L6 myotubes.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Bartłomiej Łukaszuk Research Topics

Disease

6	Obesity 09/2022 - 01/2016
5	Insulin Resistance 09/2017 - 01/2013
4	Inflammation (Inflammations) 04/2022 - 01/2013
4	Type 1 Diabetes Mellitus (Autoimmune Diabetes) 01/2020 - 01/2014
3	Pancreatitis 01/2020 - 12/2017
3	Non-alcoholic Fatty Liver Disease 08/2019 - 08/2014
3	Type 2 Diabetes Mellitus (MODY) 03/2017 - 01/2014
2	Pathologic Processes 01/2020 - 01/2013
1	Morbid Obesity 01/2022
1	Metabolic Syndrome (Dysmetabolic Syndrome X) 01/2022
1	Diabetes Mellitus 01/2020
1	Weight Loss (Weight Reduction) 09/2019
1	Infarction (Infarctions) 01/2018
1	Pancreatic Diseases (Pancreatic Disease) 12/2017
1	Fatty Liver 01/2017
1	Atrophy 11/2016
1	Neoplasms (Cancer) 04/2015
1	Adenoma (Adenomas) 04/2015
1	Polyps 04/2015
1	Adenomatous Polyps 04/2015
1	Body Weight (Weight, Body) 01/2015
1	Hyperthyroidism 01/2015
1	Ischemia 09/2013
1	Reperfusion Injury 09/2013
1	Cardiovascular Diseases (Cardiovascular Disease) 09/2013
1	Inflammatory Bowel Diseases (Inflammatory Bowel Disease) 01/2013
1	Colorectal Neoplasms (Colorectal Cancer) 01/2013
1	Carcinogenesis 01/2013

Drug/Important Bio-Agent (IBA)

9	SphingolipidsIBA 01/2020 - 01/2013
8	LipidsIBA 09/2022 - 08/2014
6	CeramidesIBA 04/2015 - 09/2013
5	Fatty Acids (Saturated Fatty Acids)IBA 09/2022 - 01/2017
5	thermozymocidin (myriocin)IBA 03/2017 - 01/2013
4	SphingomyelinsIBA 08/2019 - 09/2013
4	Streptozocin (Streptozotocin)FDA Link 10/2017 - 01/2014
3	Glucose (Dextrose)FDA LinkGeneric 03/2017 - 01/2013
2	2,3-bis(3'-hydroxybenzyl)butyrolactone (enterolactone)IBA 03/2019 - 01/2017
2	SphingosineIBA 09/2013 - 01/2013
1	Carrier Proteins (Binding Protein)IBA 09/2022
1	Matrix Metalloproteinases (MMPs)IBA 04/2022
1	Reactive Oxygen Species (Oxygen Radicals)IBA 04/2022
1	AntioxidantsIBA 04/2022
1	Proteins (Proteins, Gene)FDA Link 01/2022
1	nervonic acidIBA 08/2019
1	CeruletideIBA 01/2018
1	PolyphenolsIBA 01/2017
1	secoisolariciresinolIBA 01/2017
1	sphingosine 1-phosphate (sphingosine-1-phosphate)IBA 04/2015
1	Electron Transport Complex IV (Cytochrome c Oxidase)IBA 01/2015
1	Mitochondrial Proteins (Mitochondrial Protein)IBA 01/2015
1	Coenzyme A (CoA)IBA 01/2015
1	Oxidoreductases (Dehydrogenase)IBA 01/2015
1	Triiodothyronine (Liothyronine)FDA LinkGeneric 01/2015
1	AMP-Activated Protein KinasesIBA 01/2015
1	Peroxisome Proliferator-Activated Receptors (PPAR)IBA 01/2015
1	2- cyclohexylidenhydrazo- 4- phenyl- thiazoleIBA 01/2015
1	DiglyceridesIBA 08/2014
1	Phosphates (Orthophosphate)IBA 09/2013
1	PalmitatesIBA 01/2013
1	Serine C-PalmitoyltransferaseIBA 01/2013
1	Insulin (Novolin)FDA Link 01/2013
1	sphingosine kinaseIBA 01/2013

Therapy/Procedure

1	Operative Surgical Procedures 09/2019
1	Therapeutics 09/2019
1	Gastrectomy 09/2019